Kiniksa Pharmaceuticals KNSA Income Statements

Conto economico

Quarter End	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	26,97M	99,14M	61,88M	48,35M	71,47M	67,05M	83,4M	79,86M
Reddito operativo	-27,62M	46,41M	6,05M	-11,2M	-3,15M	-33,2M	81k	-16,54M
Reddito ante imposte	-19,27M	46,74M	6,84M	-9,36M	-1,24M	-8,5M	2,45M	-14,28M
Reddito netto	-19,98M	224,09M	4,46M	-12,27M	14,97M	-13,86M	25,24M	-17,7M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-27,62M	46,41M	6,05M	-11,2M	593k	-30,77M	2,45M	-14,28M
EBITDA	-26,97M	46,91M	6,65M	-10,6M	-2,55M	-32,6M	621k	-16,08M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	0	0	0	0	0	38,54M	220,18M	270,26M
Reddito operativo	-24M	-65,4M	-108,16M	-169,96M	-157,36M	-156,64M	9,77M	-25,2M
Reddito ante imposte	-23,94M	-64,87M	-103,44M	-163,91M	-156,23M	-156,54M	11,03M	-16,65M
Reddito netto	-23,97M	-64,87M	-103,23M	-161,87M	-161,38M	-157,92M	183,36M	14,08M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-2.795	-7.564	-1.043	-1.521	-1.454	-1.143	1.315	0.1
UTILE OPERATIVO	-24M	-65,4M	-108,16M	-169,96M	-157,36M	-156,64M	9,77M	-16,65M
EBITDA	-23,98M	-65,37M	-107,87M	-167,9M	-154,96M	-154,28M	12,18M	-22,86M